Scarica l'app Stockscreener
1.2108
10.00%
0.1108
Renovorx Inc Borsa (RNXT) Ultime notizie
RenovoRx surpasses 100 patients in Phase III pancreatic trial By Investing.com - Investing.com India
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment - The Manila Times
RenovoRx pancreatic cancer trial passes 100 patients, 2027 data next - Stock Titan
RenovoRx CFO voll acquires shares and warrants in RNXT By Investing.com - Investing.com Australia
Laurence Marton buys RenovoRx stock and warrants for $10,000 By Investing.com - Investing.com South Africa
Shaun Bagai, CEO of Renovorx, buys $0 of RNXT stock - Investing.com
Laurence Marton buys RenovoRx stock and warrants for $10,000 - Investing.com
RenovoRx (RNXT) CEO’s family trust buys shares and new warrants - Stock Titan
RenovoRx (RNXT) director adds $10K via rollover IRA private deal - Stock Titan
The most innovative medical device companies of 2026 - Fast Company
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement - Investing News Network
RenovoRx Secures $10 Million Oversubscribed Private Placement to Accelerate RenovoCath Commercialization and Advance Phase III Pancreatic Cancer Trial - Minichart
Trend Recap: Can RenovoRx Inc expand its profit margins2026 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
RenovoRx Raises $10 Million in Oversubscribed Private Placement - TipRanks
RenovoRx Raises ~$10 Million in Private Placement; Sells Stock and Warrants at $0.938 Per Share - TradingView
RenovoRx (Nasdaq: RNXT) nets $10M private placement with milestone warrants - Stock Titan
RenovoRx (RNXT) Expected to Announce Quarterly Earnings on Monday - Defense World
Panic Selling: How does RenovoRx Inc perform in inflationary periods2026 Geopolitical Influence & Entry and Exit Point Strategies - baoquankhu1.vn
Downgrade Watch: Can RenovoRx Inc deliver alphaWeekly Trade Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET - Investing News Network
Draganfly to Host Shareholder Update Call on March 24, 2026 - weeklyvoice.com
RenovoRx March 30 call to cover 2025 results, Phase III trial timing - Stock Titan
RenovoRx, Inc. announced that it has received $10 million in funding from Transcend Partners LLC, Aigh Capital Management, LLC, Bleichroeder LP, Pathfinder Asset Management Limited - marketscreener.com
Aug Wrap: Can KLRS outperform under higher oil prices2026 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Risk Off: Will cbdMD Inc outperform its industry peers2026 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn
RenovoRx raises $10M in oversubscribed private placement By Investing.com - Investing.com Australia
Support Test: Is RenovoRx Inc exposed to political riskEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
RenovoRx Announces $10 Million at Market Private Placement - Investing News Network
RenovoRx prices 10.6M shares at 93.8c in private placement - TipRanks
RenovoRx, Inc. announced that it expects to receive $10 million in funding - marketscreener.com
RenovoRx announces $10 million private placement - MSN
RenovoRx raises $10M in oversubscribed private placement - Investing.com
RenovoRx announces $10 million at market Private Placement - marketscreener.com
Renovorx Announces $10 Million At Market Private Placement - TradingView
$10M investor bet on RenovoRx cancer device and trial push - Stock Titan
Aug Fed Impact: Is RenovoRx Inc a defensive stock2026 Market Mood & Safe Capital Growth Tips - baoquankhu1.vn
RNXT Should I Buy - Intellectia AI
Gains Recap: What hedge funds are buying Arko CorpRate Cut & AI Forecast Swing Trade Picks - baoquankhu1.vn
Returns Recap: Can RenovoRx Inc expand its profit margins2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
What dividend safety score for RenovoRx Inc. stockEarnings Recap Report & Real-Time Volume Surge Alerts - Naître et grandir
Market Review: How much upside does RenovoRx Inc have2025 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
Insider Buy: Is RenovoRx Inc stock a value trapJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Macro: What chart patterns are forming on RenovoRx IncRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Block Trades: Will RenovoRx Inc benefit from rate cuts2025 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Guidance Update: Is RenovoRx Inc stock overvalued or fairly pricedJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
RenovoRx Advancing RenovoCath Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - marketscreener.com
US Market Recap: Whats the outlook for RenovoRx Incs sectorM&A Rumor & AI Enhanced Trading Alerts - baoquankhu1.vn
RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Down 20.6% in February - Defense World
RenovoRx advances RenovoCath adoption at U.S. cancer centers - Yahoo Finance
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - Investing News Network
After 700 cancer procedures, RenovoCath gets new doctor-led commercial push - Stock Titan
Targeted chemo delivery for pancreatic cancer to feature at 2026 SIR meeting - Stock Titan
RNXT PE Ratio & Valuation, Is RNXT Overvalued - Intellectia AI
RenovoRx (RNXT) Price Target Increased by 10.66% to 6.88 - Nasdaq
Hedge Fund Bets: Will eBay Inc Preferred Security stock hit new highs in YEAR2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is RenovoRx Inc. stock overvalued or fairly pricedSwing Trade & Daily Technical Forecast Reports - mfd.ru
Dow Update: How much upside does RenovoRx Inc haveJuly 2025 Market Mood & Weekly Top Stock Performers List - baoquankhu1.vn
RenovoRx (NASDAQ:RNXT) vs. MetaVia (NASDAQ:MTVA) Head-To-Head Survey - Defense World
Mark Voll Joins RenovoRx as Chief Financial Officer - Medical Product Outsourcing
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
RenovoRx (NASDAQ:RNXT) Price Target Raised to $13.00 at Ascendiant Capital Markets - Defense World
RenovoRx (RNXT): Analyst Raises Price Target Following Positive Outlook | RNXT Stock News - GuruFocus
Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Sahm
Why RenovoRx Inc. stock remains resilientTrade Performance Summary & Safe Entry Point Alerts - mfd.ru
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):